STAT+: FDA approves Replimune melanoma drug previously rejected twice
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Replimune rebounds to win FDA approval of melanoma drug biopharmadive.com



